argenx SE | ARGX - Assets

Stock Price
693.20
Daily Change
-1.00 -0.14%
Monthly
-2.45%
Yearly
37.43%
Q2 Forecast
678.23

argenx SE reported $8.68B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AstraZeneca USD 114.02B 59M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Qiagen NV USD 6.3B 257.54M Dec/2025
UCB EUR 18.16B 971M Dec/2025